TITLE:
Guillain-Barré Syndrome Following AstraZeneca COVID-19 Vaccine
AUTHORS:
Ali Mikdad Hassan, Syeda Marium, Paras Yousuf, Asad Akram Farooqi, Uzair Yaqoob
KEYWORDS:
COVID-19, Coronavirus, Vaccination, Guillain-Barre Syndrome, AstraZeneca
JOURNAL NAME:
Open Access Library Journal,
Vol.9 No.11,
November
25,
2022
ABSTRACT: It’s been more than two years since the first case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in Wuhan, China, in December 2019, and still Coronavirus-19 (COVID-19) is an ongoing burden in many parts of the world. Currently, few vaccines are approved by the World Health Organization (WHO) and are being administered to people to boost their immunity. Since the outbreak of this disease, the number of patients getting vaccinated is increasing with every passing day. Understanding the burden of the disease and the adverse effects due to its vaccination is very crucial. We report a case of Guillain-Barre Syndrome after receiving the first dose of the AstraZeneca-COVID-19 vaccine.